Novo's exit from insulin markets continues apace.
https://timesofindia.indiatimes.com/india/novo-nordisk-to-phase-out-its-largest-insulin-brand-in-india/articleshow/120501423.cms
Context: Here's what happened when they left SA: https://www.nytimes.com/2024/06/19/health/insulin-pens-south-africa-ozempic-wegovy.html?searchResultPosition=1
+ I wrote on why trusting manufacturers to be nice is dumb discontinuations policy.
https://www.healthaffairs.org/content/forefront/counting-insulin-manufacturers-do-right-thing-not-good-policy-prescription-avert
https://timesofindia.indiatimes.com/india/novo-nordisk-to-phase-out-its-largest-insulin-brand-in-india/articleshow/120501423.cms
Context: Here's what happened when they left SA: https://www.nytimes.com/2024/06/19/health/insulin-pens-south-africa-ozempic-wegovy.html?searchResultPosition=1
+ I wrote on why trusting manufacturers to be nice is dumb discontinuations policy.
https://www.healthaffairs.org/content/forefront/counting-insulin-manufacturers-do-right-thing-not-good-policy-prescription-avert
Comments